Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Principia Biopharma Inc. (PRNB)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-19Dec-31-18Dec-31-17Dec-31-16
   10-K10-K10-K10-K
Revenues  35.269.15.20.0
            Revenue growth  -49.1%1217.6%  
Cost of goods sold  0.00.00.00.0
Gross profit  35.269.15.20.0
            Gross margin  100.0%100.0%100.0% 
Selling, general and administrative   [+]19.811.56.44.8
Research and development  74.140.525.422.3
EBITDA   [+]-56.917.4-26.4-26.8
            EBITDA margin  -161.9%25.2%-503.3% 
Depreciation and amortization  1.80.30.20.2
EBIT   [+]-58.817.1-26.6-27.1
            EBIT margin  -167.1%24.8%-506.7% 
Interest expense, net   [+]-5.0-1.77.23.9
Other income (expense), net   -0.75.10.3
Pre-tax income  -53.818.2-28.7-30.6
Income taxes  0.00.00.00.0
            Tax rate   0.0%  
Net income  -53.84.9-28.7-30.6
            Net margin  -153.0%7.1%-546.9% 
   
Basic EPS   [+]($2.09)$0.65($50.37)($59.89)
Diluted EPS   [+]($2.09)$0.57($50.37)($59.89)
   
Shares outstanding (basic)   [+]25.87.60.60.5
Shares outstanding (diluted)   [+]25.88.60.60.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy